CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $53,000 | -11.7% | 12,648 | +4.5% | 0.00% | 0.0% |
| Q1 2021 | $60,000 | -80.6% | 12,099 | -61.6% | 0.00% | -70.0% |
| Q3 2020 | $309,000 | -47.8% | 31,506 | -47.1% | 0.01% | -33.3% |
| Q2 2020 | $592,000 | +10.4% | 59,513 | -1.9% | 0.02% | +7.1% |
| Q1 2020 | $536,000 | -34.5% | 60,645 | -31.6% | 0.01% | +27.3% |
| Q4 2019 | $818,000 | +408.1% | 88,702 | +224.0% | 0.01% | +450.0% |
| Q3 2019 | $161,000 | – | 27,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |